PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 132 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $798,000 | -60.7% | 10,459 | -63.9% | 0.01% | -52.9% |
| Q1 2021 | $2,032,000 | +17.1% | 29,000 | 0.0% | 0.02% | +30.8% |
| Q4 2020 | $1,735,000 | +275.5% | 29,000 | +208.5% | 0.01% | +160.0% |
| Q3 2018 | $462,000 | +0.2% | 9,400 | -34.7% | 0.01% | -16.7% |
| Q2 2018 | $461,000 | -52.9% | 14,400 | -54.1% | 0.01% | -53.8% |
| Q1 2018 | $978,000 | +155.4% | 31,400 | +273.8% | 0.01% | +225.0% |
| Q4 2017 | $383,000 | -52.5% | 8,400 | -66.4% | 0.00% | -60.0% |
| Q4 2016 | $807,000 | – | 25,000 | +49900.0% | 0.01% | – |
| Q3 2013 | $0 | -100.0% | 50 | 0.0% | 0.00% | -100.0% |
| Q2 2013 | $21,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |